Comparison of estimated human dose of 68Ga-MAA with 99mTc-MAA based on rat data

Annals of Nuclear Medicine

Volumn 29, Issue 8, 2015, Pages 745-753

  Shanehsazzadeh, Saeed ^a   Lahooti, Afsaneh ^b   Yousefnia, Hassan ^a   Geramifar, Parham ^c   Jalilian, Amir Reza ^a  

^a NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biodistribution; Effective absorbed dose; Gallium 68; Macroaggregated albumin (MAA)

Indexed keywords

MACROSALB TC 99M; GALLIUM MACROAGGREGATED HUMAN SERUM ALBUMIN; ORGANOMETALLIC COMPOUND; SERUM ALBUMIN;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; BRAIN; BREAST; CONTROLLED STUDY; DOSE CALCULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; GONAD; HEART; HUMAN; IMAGE QUALITY; KIDNEY; LARGE INTESTINE; LIVER; LUNG; MUSCLE; NONHUMAN; OVARY; PANCREAS; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RAT; SKIN; SMALL INTESTINE; SPECIES COMPARISON; SPLEEN; STOMACH; TESTIS; THYMUS; THYROID GLAND; UTERUS; WILD TYPE RAT; ANIMAL; COMPARATIVE STUDY; TISSUE DISTRIBUTION;

ANIMALS; HUMANS; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RATS; SERUM ALBUMIN; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TISSUE DISTRIBUTION;

EID: 84943348133     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-015-0997-z     Document Type: Article

References (41)

1. 68Ga-radiopharmaceutical development. Theranostics. 2014;4:47–80.
2. 61 Cu] pyruvaldehyde-bis (N-4-methylthiosemicarbazone) in normal rats as a PET tracer. Nucl Sci Tech. 2008;19:159–64.
3. Firestone RB, Shirley VS. Table of Isotopes, 2 Volume Set. In: Firestone RB, Shirley VS, editors. p. 3168. ISBN 0-471-33056-6 Wiley; 1998. p. 1.
4. 68Ga radiopharmaceutical chemistry. Curr Top Med Chem. 2010;10:1633–68.
5. Yang DJ, Kim EE, Inoue T. Targeted molecular imaging in oncology. Ann Nucl Med. 2006;20(1):1–11.
6. 67Ga-ECC. Ann Nucl Med. 2015. doi:10.1007/s12149-015-0967-5.
7. 99mTc-MAA in the diagnosis of intrapulmonary vascular dilatations. Ann Nucl Med. 2015;29:46–51.
8. Mahdavi R, Caronia J, Fayyaz J, Panagopoulos G, Lessnau K, Scharf S, et al. Agreement between SPECT V/Q scan and CT angiography in patients with high clinical suspicion of PE. Ann Nucl Med. 2013;27:834–8.
9. 68Ga-MAA. Int J Rad Appl Instrum B. 1989;16:319–21.
10. 99mTc-labeled bombesin based on distribution data in mice. J Radioanal Nucl Chem. 2015. doi:10.1007/s10967-015-3995-7.
11. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023–7.
12. Snyder W, Ford M, Warner G, Watson S. S” absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No. 11. Society of Nuclear Medicine, New York. 1975.
13. Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, et al. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40:37S–61S.
14. 67Ga–ECC based on biodistribution rat data. Ann Nucl Med. 2014;29:118–24.
15. 125I]-iodobenzylsulfonyl) piperidine in humans on the basis of biodistribution data of rats. Nucl Med Commun. 2015;36:90–4.
16. Sparks RB, Aydogan B. Comparison of the effectiveness of some common animal data scaling techniques in estimating human radiation dose. In: Sixth international radiopharmaceutical dosimetry symposium oak ridge. Oak Ridge Associated Universities; 1996. p. 705–16.
17. 99mTc-MAA microspheres. Appl Radiat Isotop. 2011;69:171–5.
18. Council B. Guidelines on the use of living animals in scientific investigations. Biological council. 1987.
19. 68Ga-MAA as Perfusion Agents. Biomedical Engineering Conference (SBEC), 2013 29th Southern; 2013: IEEE.
20. 111In-DTPA-Buserelin in human on the basis of biodistribution rat data. Radiat Prot Dosim. 2013;154:1–8.
21. 99mTc in Balb/c mice. Nucl Med Biol. 2014;41:625.
22. 67Ga]-DTPA-USPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancers. Nucl Med Commun. 2013;34:915–25.
23. 1−24-corticotrophin in normal rats. Radiochim Acta. 2008;96:435–9.
24. 111In]-DTPA-buserelin for GnRH receptor studies. Radiochim Acta. 2010;98:113–9.
25. 201Tl (III)-DTPA-HIgG based on biodistribution data in rats. Radiat Prot Dosim. 2010;141:269–74.
26. Lahooti A, Shanehsazzadeh S, Oghabian MA, Allen BJ. Assessment of human effective absorbed dose of Tc-99m-USPIO based on biodistribution rat data. J Labelled Compd Radiopharm. 2013;56:S258.
27. Shanehsazzadeh S, Oghabian MA, Lahooti A, Allen BJ. Development of ultra small super paramagnetic iron oxide nanoparticles labeled with Gallium 67 as a dual modality probe. J Labelled Compd Radiopharm. 2013;56:S236.
28. (201) Tl(III)-DTPA-HIgG based on biodistribution data in rats. J Labelled Compd Radiopharm. 2011;54:S347.
29. 67 Ga]-DTPA-gonadorelin in normal rats. J Radioanal Nucl Chem. 2008;278:123–9.
30. 67Ga-DTPA-ACTH based on distribution data in rats. Radiat Prot Dosim. 2009;134:79–86.
31. 67Ga–cDTPA–gonadorelin based on biodistribution rat data. Nucl Med Commun. 2011;32:37–43.
32. Bevelacqua J. Internal dosimetry primer. Radiat Prot. Manage. 2005;22:7–17.
33. Icrp. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007. Ann ICRP. 2008;38:1–197.
34. Oghabian MA, Gharehaghaji N, Masoudi A, Shanehsazzadeh S, Ahmadi R, Majidi RF, et al. Effect of coating materials on lymph nodes detection using magnetite nanoparticles. Adv Sci Eng Med. 2013;5:37–45.
35. Omid H, Oghabian MA, Ahmadi R, Shahbazi N, Hosseini HRM, Shanehsazzadeh S, et al. Synthesizing and staining manganese oxide nanoparticles for cytotoxicity and cellular uptake investigation. BBA Gen Subj. 2014;1840:428–33.
36. 68Ga-ECC as a PET renal imaging agent. Nucl Med Mol Imag. 2015. doi:10.1007/s13139-015-0323-7.
37. Shanehsazzadeh S, Oghabian MA, Daha FJ, Amanlou M, Allen BJ. Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice. J Radioanal Nucl Chem. 2013;295:1517–23.
38. Shanehsazzadeh S, Gruettner C, Lahooti A, Mahmoudi M, Allen BJ, Ghavami M, et al. Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo. Contrast Media Mol Imaging. 2015;10:225–36.
39. Wild D, Wicki A, Mansi R, Béhé M, Keil B, Bernhardt P, et al. Exendin-4–Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT. J Nucl Med. 2010;51:1059–67.
40. 99mTc-HYNIC-Octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial. J Nucl Med. 2014;55:1598–604.
41. 99mTc-MAA. Nucl Med Biol. 2012;39:1026–33.